ArticleCardiovascular diabetology2023

Kidney function loss and albuminuria progression with GLP-1 receptor agonists versus basal insulin in patients with type 2 diabetes: real-world evidence.

Meir Schechter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.